Iatrogenic Opioid Withdrawal Syndrome in Critically Ill Patients: a Retrospective Cohort Study

• Published in: Journal of Korean medical science 2020, 35(15), , pp.1-12
• Main Authors: Hyun, Dong Gon, Huh, Jin Won, Hong, Sang Bum, Koh, Younsuck, Lim, Chae Man
• Format: Article
• Language: English
• Subjects: Aged; Analgesics, Opioid - administration & dosage; Critical Illness; Female; Fentanyl - administration & dosage; Humans; Incidence; Male; Middle Aged; Morphine - administration & dosage; Multivariate Analysis; Original; Proportional Hazards Models; Remifentanil - administration & dosage; Republic of Korea - epidemiology; Respiratory Rate; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Shock, Septic - complications; Shock, Septic - diagnosis; Substance Withdrawal Syndrome - complications; Substance Withdrawal Syndrome - diagnosis; Substance Withdrawal Syndrome - epidemiology; 의학일반
• ISSN: 1011-8934; 1598-6357
• DOI: 10.3346/jkms.2020.35.e106

Opioid withdrawal syndrome (OWS) may occur following the reduction or discontinuation of opioid analgesics. In critically ill pediatric patients, OWS is a common and clinically significant condition. However, OWS in adult patients has not been assessed in detail. Therefore, we aimed to investigate the incidence, risk factors, and clinical features of OWS in mechanically ventilated patients treated in an adult intensive care unit (ICU). This study was a retrospective evaluation of data from patients treated in the medical ICU for > 3 days and who received only one type of opioid analgesic. OWS was assessed over a 24 hours period from discontinuation or reduction (by > 50%) of continuous opioid infusion. OWS was defined as the presence of ≥ 3 central nervous system or autonomic nervous system symptoms. In 126 patients treated with remifentanil (n = 58), fentanyl (n = 47), or morphine (n = 21), OWS was seen in 31.0%, 36.2%, and 9.5% of patients, respectively ( = 0.078). The most common symptom was a change in respiratory rate (remifentanil, 94.4%; fentanyl, 76.5%; morphine, 100%). Multivariate Cox-proportional hazards model showed that OWS was negatively associated with morphine treatment (hazard ratio [HR], 0.17; 95% confidence interval [CI], 0.037-0.743) and duration of opioid infusion (HR, 0.566; 95% CI, 0.451-0.712). OWS is not uncommon in mechanically ventilated adult patients who received continuous infusion of opioids for > 3 days. The use of morphine may be associated with a decreased risk of OWS.